Overexpression of the urokinase receptor mRNA splice variant uPAR-del4/5 affects tumor-associated processes of breast cancer cells in vitro and in vivo

Breast Cancer Research and Treatment

Volumn 127, Issue 3, 2011, Pages 649-657

  Sato, Sumito ^a,b   Kopitz, Charlotte ^a   Grismayer, Bettina ^a   Beaufort, Nathalie ^a   Reuning, Ute ^a   Schmitt, Manfred ^a   Luther, Thomas ^c   Kotzsch, Matthias ^c   Krüger, Achim ^a   Magdolen, Viktor ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Yokohama Asahi Central and General Hospital   (Japan)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Adhesion; Breast cancer; Invasion; Splice variant; Tumor xenograft; uPAR

Indexed keywords

MESSENGER RNA; UROKINASE; UROKINASE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; BREAST CANCER; CANCER CELL; CELL ADHESION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PHENOTYPE; PLASMID; PRIORITY JOURNAL; PROTEIN INTERACTION; RNA SPLICING; TUMOR XENOGRAFT;

ALTERNATIVE SPLICING; ANIMALS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; RNA, MESSENGER; SEQUENCE DELETION;

EID: 79958277643     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1042-5     Document Type: Article

References (35)

1. F Blasi N Sidenius 2010 The urokinase receptor: focused cell surface proteolysis, cell adhesion and signaling FEBS Lett 584 1923 1930 20036661 10.1016/j.febslet.2009.12.039 1:CAS:528:DC%2BC3cXkvFOjsrk%3D
2. F Blasi P Carmeliet 2002 uPAR: a versatile signalling orchestrator Nat Rev Mol Cell Biol 3 932 943 12461559 10.1038/nrm977 1:CAS:528: DC%2BD38XptFKnt7c%3D (Pubitemid 35477371)
3. U Reuning V Magdolen O Wilhelm K Fischer V Lutz H Graeff M Schmitt 1998 Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis Int J Oncol 13 893 906 9772277 1:CAS:528:DyaK1cXnsV2iu7s%3D (Pubitemid 28506055)
4. N Harbeck RE Kates K Gauger A Willems M Kiechle V Magdolen M Schmitt 2004 Urokinase-type plasminogen activator (uPA) and its inhibitor PAI-I: novel tumor-derived factors with a high prognostic and predictive impact in breast cancer Thromb Haemost 91 450 456 14983219 1:CAS:528:DC%2BD2cXitV2nu7g%3D (Pubitemid 38396866)
5. G Høyer-Hansen IK Lund 2007 Urokinase receptor variants in tissue and body fluids Adv Clin Chem 44 65 102 17682340 10.1016/S0065-2423(07)44003-3
6. L Harris H Fritsche R Mennel L Norton P Ravdin S Taube MR Somerfield DF Hayes RC Bast 2007 American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer J Clin Oncol 25 5287 5312 17954709 10.1200/JCO.2007.14.2364 1:CAS:528:DC%2BD2sXhsVKnsbzK (Pubitemid 350232263)
7. M Ploug 2003 Structure-function relationships in the interaction between the urokinase-type plasminogen activator and its receptor Curr Pharm Des 9 1499 1528 12871065 10.2174/1381612033454630 1:CAS:528:DC%2BD3sXksFGntrs%3D (Pubitemid 36758313)
8. HW Smith CJ Marshall 2010 Regulation of cell signalling by uPAR Nat Rev Mol Cell Biol 11 23 36 20027185 10.1038/nrm2821 1:CAS:528:DC%2BD1MXhsFymtb7M
9. Reuning U, Magdolen V, Hapke S, Schmitt M (2003) Molecular and functional interdependence of the urokinase-type plasminogen activator system with integrins. Biol Chem 384:1119-1131 (Pubitemid 37121185)
10. P Llinas MH Le Du H Gårdsvoll K Danø M Ploug B Gilquin EA Stura A Ménez 2005 Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide EMBO J 24 1655 1663 15861141 10.1038/sj.emboj.7600635 1:CAS:528:DC%2BD2MXksFKisLg%3D (Pubitemid 40704976)
11. Q Huai AP Mazar A Kuo GC Parry DE Shaw J Callahan Y Li C Yuan C Bian L Chen B Furie BC Furie DB Cines M Huang 2006 Structure of human urokinase plasminogen activator in complex with its receptor Science 311 656 659 16456079 10.1126/science.1121143 1:CAS:528:DC%2BD28XptVyltA%3D%3D (Pubitemid 43191309)
12. H Gårdsvoll M Ploug 2007 Mapping of the vitronectin-binding site on the urokinase receptor: involvement of a coherent receptor interface consisting of residues from both domain I and the flanking interdomain linker region J Biol Chem 282 13561 13572 17355965 10.1074/jbc.M610184200 (Pubitemid 47100512)
13. Q Huai A Zhou L Lin AP Mazar GC Parry J Callahan DE Shaw B Furie BC Furie M Huang 2008 Crystal structures of two human vitronectin, urokinase and urokinase receptor complexes Nat Struct Mol Biol 15 422 423 18376415 10.1038/nsmb.1404 1:CAS:528:DC%2BD1cXktFyjtLY%3D (Pubitemid 351483393)
14. CE Stewart I Sayers 2009 Characterisation of urokinase plasminogen activator receptor variants in human airway and peripheral cells BMC Mol Biol 10 75 19638192 10.1186/1471-2199-10-75
15. T Luther M Kotzsch A Meye T Langerholc S Fussel N Olbricht S Albrecht D Ockert B Muehlenweg K Friedrich M Grosser M Schmitt G Baretton V Magdolen 2003 Identification of a novel urokinase receptor splice variant and its prognostic relevance in breast cancer Thromb Haemost 89 705 717 12669126 1:CAS:528:DC%2BD3sXjtl2ntr4%3D (Pubitemid 36456968)
16. C Pyke J Eriksen H Solberg BS Nielsen P Kristensen LR Lund K Danø 1993 An alternatively spliced variant of mRNA for the human receptor for urokinase plasminogen activator FEBS Lett 326 69 74 8392005 10.1016/0014- 5793(93)81763-P 1:CAS:528:DyaK3sXlslKitLg%3D (Pubitemid 23200249)
17. M Kotzsch J Farthmann A Meye S Fuessel G Baretton VC Tjan-Heijnen M Schmitt T Luther FC Sweep V Magdolen PN Span 2005 Prognostic relevance of uPAR-del4/5 and TIMP-3 mRNA expression levels in breast cancer Eur J Cancer 41 2760 2768 16256342 10.1016/j.ejca.2005.09.002 1:CAS:528:DC%2BD2MXht1Srtb7M (Pubitemid 41607570)
18. M Kotzsch AM Sieuwerts M Grosser A Meye S Fuessel ME Meijer-van Gelder M Smid M Schmitt G Baretton T Luther V Magdolen JA Foekens 2008 Urokinase receptor splice variant uPAR-del4/5-associated gene expression in breast cancer: identification of rab31 as an independent prognostic factor Breast Cancer Res Treat 111 229 240 17952591 10.1007/s10549-007-9782-6 1:CAS:528: DC%2BD1cXptVCntLg%3D
19. V Möbus CD Gerharz U Press R Moll T Beck W Mellin K Pollow PG Knapstein R Kreienberg 1992 Morphological, immunohistochemical and biochemical characterization of 6 newly established human ovarian carcinoma cell lines Int J Cancer 52 76 84 1500230 10.1002/ijc.2910520115
20. T Luther V Magdolen S Albrecht M Kasper C Riemer H Kessler H Graeff M Müller M Schmitt 1997 Epitope-mapped monoclonal antibodies as tools for functional and morphological analyses of the human urokinase receptor in tumor tissue Am J Pathol 150 1231 1244 9094980 1:CAS:528:DyaK2sXis12hsr8%3D (Pubitemid 27152642)
21. L Goretzki J Bognacki M Koppitz P Rettenberger V Magdolen S Creutzburg J Hammelburger UH Weidle O Wilhelm H Kessler H Graeff M Schmitt 1997 Quantitative assessment of interaction of urokinase-type plasminogen activator and its receptor (CD87) by use of a solid-phase uPA-ligand binding assay Fibrinol Proteol 11 11 19 10.1016/S0268-9499(97)80004-5 1:CAS:528:DyaK2sXislalu74%3D (Pubitemid 27173611)
22. A Krüger R Soeltl I Sopov C Kopitz M Arlt V Magdolen N Harbeck B Gänsbacher M Schmitt 2001 Hydroxamate-type matrix metalloproteinase inhibitor batimastat promotes liver metastasis Cancer Res 61 1272 1275 11245418 (Pubitemid 34292540)
23. C Kopitz M Anton B Gänsbacher A Krüger 2005 Reduction of experimental human fibrosarcoma lung metastasis in mice by adenovirus-mediated cystatin C overexpression in the host Cancer Res 65 8608 8612 16204025 10.1158/0008-5472.CAN-05-1572 1:CAS:528:DC%2BD2MXhtVKiurfK (Pubitemid 41377344)
24. A Krüger V Schirrmacher R Khokha 1998 The bacterial lacZ gene: an important tool for metastasis research and evaluation of new cancer therapies Cancer Metastasis Rev 17 285 294 10352882 10.1023/A:1006066706040 (Pubitemid 29210168)
25. N Beaufort D Leduc H Eguchi K Mengele D Hellmann T Masegi T Kamimura S Yasuoka F Fend M Chignard D Pidard 2007 The human airway trypsin-like protease modulates the urokinase receptor (uPAR, CD87) structure and functions Am J Physiol Lung Cell Mol Physiol 292 1263 1272 10.1152/ajplung.00191.2006 (Pubitemid 47084872)
26. Y Wei M Lukashev DI Simon SC Bodary S Rosenberg MV Doyle HA Chapman 1996 Regulation of integrin function by the urokinase receptor Science 273 1551 1555 8703217 10.1126/science.273.5281.1551 1:CAS:528:DyaK28Xls1WqsLk%3D (Pubitemid 26301666)
27. W Xue I Mizukami RF Todd HR Petty 1997 Urokinase-type plasminogen activator receptors associate with beta1 and beta3 integrins of fibrosarcoma cells: dependence on extracellular matrix components Cancer Res 57 1682 1689 9135008 1:CAS:528:DyaK2sXjtFelsLc%3D (Pubitemid 27199659)
28. A Krüger R Soeltl V Lutz OG Wilhelm V Magdolen EE Rojo PA Hantzopoulos H Graeff B Gänsbacher M Schmitt 2000 Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87) Cancer Gene Ther 7 292 299 10770639 10.1038/sj.cgt.7700144 (Pubitemid 30194565)
29. B Setyono-Han J Sturzebecher WA Schmalix B Muehlenweg AM Sieuwerts M Timmermans V Magdolen M Schmitt JG Klijn JA Foekens 2005 Suppression of rat breast cancer metastasis and reduction of primary tumour growth by the small synthetic urokinase inhibitor WX-UK1 Thromb Haemost 93 779 786 15841327 1:CAS:528:DC%2BD2MXjs1ert78%3D (Pubitemid 40485417)
30. AJ Ward TA Cooper 2010 The pathobiology of splicing J Pathol 220 152 163 19918805 1:CAS:528:DC%2BC3cXht1OnsLc%3D
31. JD Fackenthal LA Godley 2008 Aberrant RNA splicing and its functional consequences in cancer cells Dis Model Mech 1 37 42 19048051 10.1242/dmm.000331 1:CAS:528:DC%2BD1cXht1yis7fF
32. TK Bjarnadóttir K Geirardsdóttir M Ingemansson MA Mirza R Fredriksson HB Schiöth 2007 Identification of novel splice variants of Adhesion G protein-coupled receptors Gene 387 38 48 17056209 10.1016/j.gene.2006.07.039 (Pubitemid 44959561)
33. D Alfano P Franco I Vocca N Gambi V Pisa A Mancini M Caputi MV Carriero I Iaccarino MP Stoppelli 2005 The urokinase plasminogen activator and its receptor: role in cell growth and apoptosis Thromb Haemost 93 205 211 15711734 1:CAS:528:DC%2BD2MXhs1Kgu70%3D (Pubitemid 40253723)
34. MK Durand JS Bodker A Christensen DM Dupont M Hansen JK Jensen S Kjelgaard L Mathiasen KE Pedersen S Skeldal T Wind PA Andreasen 2004 Plasminogen activator inhibitor-I and tumour growth, invasion, and metastasis Thromb Haemost 91 438 449 14983218 1:CAS:528:DC%2BD2cXitV2nu7s%3D (Pubitemid 38396865)
35. PS Steeg 2003 Metastasis suppressors alter the signal transduction of cancer cells Nat Rev Cancer 3 55 63 12509767 10.1038/nrc967 1:CAS:528: DC%2BD38XpvVertbw%3D (Pubitemid 37328887)